CA-SYSDIG,-INC.
Sysdig, Inc., the secure DevOps leader, today announced a $188 million Series F funding round at a valuation of $1.19 billion. This round brings Sysdig ’s total funding to $394 million since inception. The financing was led by Premji Invest & Associates and Third Point Ventures, with participation from Accel, Bain Capital Ventures, DFJ Growth, Glynn Capital, Goldman Sachs, Insight Partners, and Next47. The company also announced that Robert Schwartz from Third Point Ventures, Sandesh Patnam from Premji Invest & Associates, and Enrique Salem from Bain Capital Ventures have joined its board of directors .
Blog from CEO Suresh Vasudevan: Our $188M funding round fuels our mission to help customers confidently run modern cloud applications
The Sysdig Secure DevOps Platform uniquely addresses the challenges of securing containers, Kubernetes, and public cloud infrastructure. Sysdig is trusted by hundreds of leading enterprises, including Worldpay by FIS, Yahoo Japan, IBM, and JW Player to confidently run modern cloud applications while managing security risks and meeting compliance requirements.
This round follows strong growth in 2020, a rapidly expanding customer base, a thriving open source community, and a massive growth opportunity with containers and cloud.
Key Milestones:
- New annual contract value (ACV) added during the second half of the 2021 fiscal year (FY21) was 2.3 times the amount added in the same period, the previous fiscal year,* reflecting increasing cloud adoption and momentum throughout 2020.
- 450 enterprise customers, including dozens of large global enterprises, with an average annual recurring revenue (ARR) of more than $500,000 across the top 50 purchasing customers.
- Strong pattern of expansion by customers as demonstrated by an annual net revenue retention (NRR) of 140% at the end of FY21.
- With nearly 24 million downloads, including 1.7 million in the last month, Falco adoption has increased 300% in the last year.
- Sysdig significantly expanded the total addressable market (TAM) beyond container and Kubernetes security to include cloud security with the addition of continuous cloud security posture management (CSPM) in 2021. The served addressable market (SAM) also increased with the delivery of more than 50 significant features last year, including the first inline scanning for Fargate , zero trust network security , and cloud-scale Prometheus monitoring .
*The 2021 fiscal year ran from February 2020 - January 2021.
In November 2020, Gartner increased its 2021 public cloud forecast to total $304.9 billion, up from $257.5 billion in 2020. [1] Modern applications are increasingly built as highly distributed microservices, leveraging containers and Kubernetes, and a vast array of services on public cloud platforms. While this shift accelerates innovation, it presents unique challenges that legacy security tools, built with a proprietary, firewall mindset, are unable to address. To manage risk without slowing down application delivery, companies need a security stack:
- Architected for secure DevOps.
- Built on open source to accelerate innovation and drive standardization.
- Delivered as SaaS for simplicity and scale.
- That provides deep visibility across containers and cloud.
Run Containers, Kubernetes, and Cloud Applications Confidently with Secure DevOps
The Sysdig Secure DevOps Platform provides security and visibility to confidently run containers, Kubernetes, and cloud. Customers rely on the platform to secure the software build pipeline, detect and respond to runtime threats, monitor service health, and continuously validate cloud security posture and compliance.
Sysdig’s SaaS deployment model and curated, out-of-the-box workflows enable companies to reduce security risk while also improving operational efficiency by 25-50 percent. With functionality that spans cloud security posture, cloud workload protection platform, and container monitoring markets, 85 percent of new customers purchase the platform solution, replacing three point solutions.
Sysdig was founded as an open source company and the Sysdig Secure DevOps Platform was built on an open source foundation to address the security challenges of modern cloud applications. Open source sysdig and Falco are projects that were created by Sysdig to leverage deep visibility as a foundation for security, and they have become standards for container and cloud threat detection and incident response. Falco, which was contributed to the Cloud Native Computing Foundation (CNCF) in 2018, is now an incubating-hosted level project. Last year, Sysdig announced full compatibility and scalability for Prometheus, the CNCF project second in popularity to Kubernetes. Sysdig’s CSPM capability incorporates the popular Cloud Custodian, a CNCF project for static configuration checks.
Focus of this Investment
This new round of investment will enable Sysdig to invest in continued innovation in its open source foundation as well as in its secure DevOps platform, and grow research and development teams in Raleigh, Spain, Italy, Belgrade, and San Francisco. The funding will drive expansion of sales and marketing in existing markets within the United States, Europe, Japan, and Australia, as well as entry into newer markets in the Asia-Pacific region. A key emphasis will be on continuing to build ecosystem and channel partnerships and local SaaS regions around the globe.
Quotes
Enrique Salem, Partner, Bain Capital Ventures: “The current security stack based on a firewall mentality and promoted by incumbents is irrelevant in the cloud. Sysdig takes a secure DevOps approach, allowing teams to ship cloud apps faster while managing security risk. They built on an open source security stack, which we see accelerates innovation and adoption.”
Sandesh Patnam, US Managing Partner, Premji Invest & Associates: “The cloud is driving a transformative shift in the way applications are developed and secured. This levels the playing field for young, innovative companies to emerge as leaders in this new, exciting category. We are extremely deliberate in our investments and expect Sysdig will not only have a successful IPO, but deliver strong long-term returns in the public market.”
Robert Schwartz, Managing Partner, Third Point Ventures: “Sysdig took several steps early on that differentiated it from other solutions, including taking an open source approach to container and Kubernetes security well before others jumped on the bandwagon. This has paid off tremendously for them. Sysdig has a marquee customer base and proven its ability to scale. We’re excited to be joining the Sysdig team and can’t wait to help them accelerate from here.”
Ping Li, Partner, Accel: “Accel partnered with Sysdig early on, with a belief that a DevSecOps stack, based on open source, deployed as SaaS is a winning formula. Today, they are the clear leader in runtime security for containers and cloud.”
Suresh Vasudevan, Chief Executive Officer, Sysdig: “Sysdig was founded as an open source company and architected for secure DevOps. In contrast, Palo Alto was founded as a proprietary firewall company, and that mindset slows app delivery in the cloud. The leading security stack for cloud delivered apps will be built on open source with a secure DevOps approach that delivers deep visibility into containers and cloud.”
[1] Gartner, Gartner Forecasts Worldwide Public Cloud End-User Spending to Grow 18% in 2021, Katie Costello and Meghan Rimol, 17 November 2020
About Sysdig
Sysdig is driving the secure DevOps movement, empowering organizations to confidently secure containers, Kubernetes, and cloud. With Sysdig, teams secure the build, detect and respond to threats, continuously validate cloud posture and compliance, and monitor performance. Sysdig is a SaaS platform, built on an open source stack that includes Falco and sysdig OSS, the open standards for runtime threat detection and response. Hundreds of companies rely on Sysdig for container and cloud security and visibility. Learn more at www.sysdig.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005369/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom